The healthcare sector will register the most rapid demand gains of any major single-use battery market, averaging 5.9 percent per year through 2020, much faster than the overall single-use battery market growth of just 1.5 percent annually. Growth will be bolstered by the rising numbers of elderly people, who are generally the most intensive users of battery-driven medical devices and instruments. Among the healthcare products employing single-use batteries are defibrillators, drug pumps, glucose monitors, heart monitors, neurostimulation and neuromodulation systems, and pacemakers. These and other trends are presented in Single-Use (Primary) Batteries in the US, a new study from The Freedonia Group, a Cleveland-based industry research firm.

Similarly, the increasing incidence of diabetes, particularly type 2 (non-insulin-dependent diabetes mellitus), in the US will promote replacement sales of single-use batteries, such as CR2032 lithium types, that are used in glucometers. Faster advances will be restrained by a trend toward the use of rechargeable batteries in glucometers. EaglePicher Technologies, Integer, and Quallion (EnerSys) are leading suppliers of single-use batteries to the healthcare market.

Single-Use (Primary) Batteries in the US (published 11/2016, 114 pages) is available for $4900 from The Freedonia Group. For further details or to arrange an interview with the analyst, please contact Corinne Gangloff by phone 440.684.9600 or email pr@freedoniagroup.com.